======= TMEM8C ======= == Gene Information == * **Official Symbol**: MYMK * **Official Name**: myomaker, myoblast fusion factor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=389827|389827]] * **UniProt**: [[https://www.uniprot.org/uniprot/A6NI61|A6NI61]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TMEM8C&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TMEM8C|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615345|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Myoblast-specific protein that mediates myoblast fusion, an essential step for the formation of multi-nucleated muscle fibers. Actively participates in the membrane fusion reaction. Associates with MYMX to promote myoblast fusion. {ECO:0000269|PubMed:28681861}. |DUF3522| |positive regulation of skeletal muscle hypertrophy| |regulation of skeletal muscle hypertrophy| |myoblast fusion involved in skeletal muscle regeneration| |positive regulation of muscle adaptation| |myotube differentiation involved in skeletal muscle regeneration| |regulation of skeletal muscle adaptation| |plasma membrane fusion| |myoblast fusion| |positive regulation of muscle hypertrophy| |skeletal muscle tissue regeneration| |cell-cell fusion| |syncytium formation by plasma membrane fusion| |syncytium formation| |myotube differentiation| |regulation of muscle hypertrophy| |integral component of Golgi membrane| |tissue regeneration| |regulation of muscle adaptation| |membrane fusion| |regeneration| |striated muscle cell differentiation| |regulation of muscle system process| |muscle cell differentiation| |muscle organ development| |developmental growth| |growth| |muscle structure development| |wound healing| |response to wounding| |regulation of system process| |membrane organization| |anatomical structure formation involved in morphogenesis| |integral component of plasma membrane| |positive regulation of multicellular organismal process| |tissue development| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|1.72| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|1.79| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|2.03| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|2.38| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9804 * **Expression level (log2 read counts)**: -2.51 {{:chemogenomics:nalm6 dist.png?nolink |}}